Revolution Ascend

The Revolution Ascend is a computed tomography X-ray system designed to produce cross-sectional images of the body for diagnostic and therapeutic guidance across a wide range of applications, including head, whole body, cardiac, and vascular imaging in patients of all ages. It utilizes computer reconstruction of X-ray transmission data acquired from various angles and planes, incorporating an updated detector with an alternative scintillator material, while maintaining identical system performance and features like Deep Learning Iterative Reconstruction.

The Revolution Ascend is a comprehensive computed tomography (CT) system designed for producing cross-sectional images of the human body. Its core components include a gantry with a 75 cm bore and a 64-row detector, a patient table, an operator console, and sophisticated image acquisition and reconstruction hardware/software. The system supports multiple acquisition modes such as Axial, Cine, Helical (Volumetric), Cardiac, and Gated acquisitions. A key modification in this version is the introduction of an alternative scintillator material in its Merc40H detector, replacing the Merc40L detector of the predicate device; however, the design and manufacturing ensure that overall system performance, features (including Deep Learning Iterative Reconstruction - DLIR), options, and specifications remain identical to its predecessor. The system is intended for head, whole body, cardiac, and vascular X-ray CT applications for patients of all ages, capable of generating images with or without contrast media. These images serve as a crucial tool for diagnosing diseases, trauma, or abnormalities, as well as for planning, guiding, and monitoring therapeutic interventions. The device processes X-ray transmission data collected at various angles and planes, allowing for the creation of images in trans-axial and reformatted planes, which can be further post-processed for additional imaging views or analytical results. Non-clinical testing, including image quality performance evaluations, has been conducted to demonstrate its equivalence to the predicate device.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific alternative scintillator material is used in the Merc40H detector, and how do its intrinsic properties (e.g., light output, decay time, afterglow, radiation hardness) compare to the material in the predicate Merc40L detector?; The document states system performance remains identical. What specific quantitative image quality metrics (e.g., low-contrast detectability at various dose levels, spatial resolution, noise power spectrum, CT number accuracy) were used to rigorously confirm this equivalence between the Merc40H and Merc40L detectors?; How does the alternative scintillator material in the Merc40H detector impact the system's dose efficiency, and are there any adjustments to acquisition protocols recommended to optimize image quality versus radiation dose?; Considering the integration of Deep Learning Iterative Reconstruction (DLIR), how was the performance of DLIR specifically re-substantiated with the raw data characteristics from the new Merc40H detector, particularly for subtle or low-attenuation difference pathologies?; For dynamic applications like cardiac and cine imaging, what are the demonstrable effects, if any, of the new detector material on temporal resolution, artifact generation, or quantitative accuracy (e.g., perfusion measurements)?